Logo image of IVG.MI

IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:IVG - NL0015000LU4 - Common Stock

18.745 EUR
0 (0%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, IVG scores 4 out of 10 in our fundamental rating. IVG was compared to 110 industry peers in the Machinery industry. There are concerns on the financial health of IVG while its profitability can be described as average. IVG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

IVG had positive earnings in the past year.
In the past year IVG had a positive cash flow from operations.
Of the past 5 years IVG 4 years were profitable.
Each year in the past 5 years IVG had a positive operating cash flow.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

IVG's Return On Assets of 1.73% is in line compared to the rest of the industry. IVG outperforms 40.91% of its industry peers.
Looking at the Return On Equity, with a value of 12.39%, IVG is in the better half of the industry, outperforming 73.64% of the companies in the same industry.
IVG has a Return On Invested Capital of 4.53%. This is comparable to the rest of the industry: IVG outperforms 42.73% of its industry peers.
IVG had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 8.83%.
The 3 year average ROIC (3.91%) for IVG is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROIC 4.53%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

With a Profit Margin value of 2.17%, IVG is not doing good in the industry: 61.82% of the companies in the same industry are doing better.
IVG's Profit Margin has improved in the last couple of years.
The Operating Margin of IVG (5.00%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of IVG has grown nicely.
IVG's Gross Margin of 16.49% is on the low side compared to the rest of the industry. IVG is outperformed by 91.82% of its industry peers.
In the last couple of years the Gross Margin of IVG has grown nicely.
Industry RankSector Rank
OM 5%
PM (TTM) 2.17%
GM 16.49%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
The number of shares outstanding for IVG has been reduced compared to 1 year ago.
The number of shares outstanding for IVG has been increased compared to 5 years ago.
The debt/assets ratio for IVG has been reduced compared to a year ago.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

IVG has an Altman-Z score of 1.77. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.77, IVG perfoms like the industry average, outperforming 42.73% of the companies in the same industry.
IVG has a debt to FCF ratio of 14.82. This is a negative value and a sign of low solvency as IVG would need 14.82 years to pay back of all of its debts.
IVG has a worse Debt to FCF ratio (14.82) than 71.82% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that IVG has dependencies on debt financing.
IVG has a Debt to Equity ratio of 1.35. This is amonst the worse of the industry: IVG underperforms 82.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Altman-Z 1.77
ROIC/WACC0.62
WACC7.3%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.98 indicates that IVG should not have too much problems paying its short term obligations.
IVG has a Current ratio of 1.98. This is in the better half of the industry: IVG outperforms 74.55% of its industry peers.
IVG has a Quick Ratio of 1.40. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IVG (1.40) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.4
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The earnings per share for IVG have decreased strongly by -23.43% in the last year.
IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.82% yearly.
Looking at the last year, IVG shows a decrease in Revenue. The Revenue has decreased by -7.24% in the last year.
Measured over the past years, IVG shows a small growth in Revenue. The Revenue has been growing by 5.06% on average per year.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%

3.2 Future

IVG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
The Revenue is expected to grow by 4.30% on average over the next years.
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.99, which indicates a correct valuation of IVG.
Based on the Price/Earnings ratio, IVG is valued cheaper than 81.82% of the companies in the same industry.
IVG is valuated rather cheaply when we compare the Price/Earnings ratio to 26.57, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.69, the valuation of IVG can be described as very reasonable.
IVG's Price/Forward Earnings ratio is rather cheap when compared to the industry. IVG is cheaper than 88.18% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, IVG is valued rather cheaply.
Industry RankSector Rank
PE 13.99
Fwd PE 8.69
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IVG is valued a bit cheaper than 80.00% of the companies in the same industry.
IVG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IVG is cheaper than 68.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.71
EV/EBITDA 5.56
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y1.82%
EPS Next 3Y8.15%

4

5. Dividend

5.1 Amount

IVG has a Yearly Dividend Yield of 1.76%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.55, IVG pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.00, IVG has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.76%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

IVECO GROUP NV

BIT:IVG (12/23/2025, 7:00:00 PM)

18.745

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-05 2026-02-05/amc
Inst Owners37.12%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.08B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts72.31
Price Target20.11 (7.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.76%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-11.27%
EPS NY rev (3m)-13.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-3.12%
Revenue NY rev (3m)-3.07%
Valuation
Industry RankSector Rank
PE 13.99
Fwd PE 8.69
P/S 0.34
P/FCF 12.71
P/OCF 3.94
P/B 1.96
P/tB 9.21
EV/EBITDA 5.56
EPS(TTM)1.34
EY7.15%
EPS(NY)2.16
Fwd EY11.5%
FCF(TTM)1.47
FCFY7.87%
OCF(TTM)4.75
OCFY25.35%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.43
Graham Number17
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROCE 6%
ROIC 4.53%
ROICexc 5.79%
ROICexgc 7.34%
OM 5%
PM (TTM) 2.17%
GM 16.49%
FCFM 2.7%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Debt/EBITDA 2.37
Cap/Depr 119.97%
Cap/Sales 6%
Interest Coverage 250
Cash Conversion 86.98%
Profit Quality 124.22%
Current Ratio 1.98
Quick Ratio 1.4
Altman-Z 1.77
F-Score6
WACC7.3%
ROIC/WACC0.62
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-22.36%
EPS Next 2Y1.82%
EPS Next 3Y8.15%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-5.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.67%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year64.49%
EBIT Next 3Y27.62%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%

IVECO GROUP NV / IVG.MI FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.


Can you provide the valuation status for IVECO GROUP NV?

ChartMill assigns a valuation rating of 5 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.


What is the profitability of IVG stock?

IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.


Can you provide the financial health for IVG stock?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


What is the earnings growth outlook for IVECO GROUP NV?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -22.36% in the next year.